This approach revealed that many MART-1 and some gp100 and MAGEA1 reactive TCR sequences co-clustered with the TCR sequences obtained from the patients’ tumor infiltrates suggesting that the respective cluster is directed against these MDAs/CTAs. The gene discussed is PMEL; the disease is neoplasm.